CONCARLO HOLDINGS
Concarlo Holdings focuses on developing solutions for drug-resistant breast cancer. Its technologies, including IpY, a cdk inhibitor, as well as ApY, an antibody focus on increasing drug efficacy and diagnostic evaluations for ER/PR+ Her 2- patients.
CONCARLO HOLDINGS
Social Links:
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2016-07-01
Address:
Brooklyn, New York, United States
Country:
United States
Website Url:
http://www.concarlo.com
Total Employee:
1+
Status:
Active
Contact:
917-856-9688
Email Addresses:
[email protected]
Total Funding:
100 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Contact Form 7 GoDaddy DNS
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
New York State
New York State investment in Seed Round - Concarlo Holdings
Accelerate New York Seed Fund
Accelerate New York Seed Fund investment in Seed Round - Concarlo Holdings
Official Site Inspections
http://www.concarlo.com Semrush global rank: 1.8 M Semrush visits lastest month: 12.67 K
- Host name: 58.0.153.160.host.secureserver.net
- IP address: 160.153.0.58
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Concarlo Holdings"
About Us - Concarlo Therapeutics
We’re cleaning up what precision oncology leaves behind Vision Concarlo’s vision is to create a world of possibility, hope and time by making cancer a treatable, manageable and survivable …See details»
Concarlo Therapeutics - Crunchbase Company Profile …
Concarlo Therapeutics is a preclinical-stage oncology company developing transformative therapeutics to target drug-resistant cancers.See details»
Concarlo Holdings - Org Chart, Teams, Culture & Jobs | The Org
View Concarlo Holdings' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Concarlo Therapeutics - Funding, Financials, Valuation & Investors
Concarlo Therapeutics is a preclinical-stage oncology company developing transformative therapeutics to target drug-resistant cancers.See details»
Concarlo - Company Profile - Tracxn
Feb 8, 2025 Concarlo - Developer of therapies for treating breast cancer. Raised a total funding of $1.45M over 2 rounds from 6 investors.See details»
Concarlo Therapeutics - Contacts, Employees, Board Members, …
Concarlo Therapeutics is a preclinical-stage oncology company developing transformative therapeutics to target drug-resistant cancers.See details»
Concarlo Therapeutics - BIO International Convention | BIO
Jun 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
Technology - Concarlo Therapeutics
Concarlo’s novel approach directly drugs the p27 protein which controls CDK4/6/2 activity. Concarlo is leveraging its deep understanding of this pathway to develop new treatments for a …See details»
Concarlo Therapeutics Overview | SignalHire Company Profile
Overview Concarlo Therapeutics is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology area. The position of the President is …See details»
Concarlo Holdings, LLC - VentureRadar
START-UP NY 858 Therapeutics 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in …See details»
Concarlo Holdings - Overview, News & Similar companies
Jul 26, 2022 View Concarlo Holdings (www.concarlo.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Concarlo | BioAdvance Capital
Concarlo is a women-founded and run company that is working to revolutionize the metastatic breast cancer field. The company is developing a new approach to inhibition of CDK4 that …See details»
Contact us - Concarlo Therapeutics
Get in touch! For press-related inquiries, reach out to [email protected]See details»
Concarlo Expands Executive Leadership Team with the …
Jun 2, 2022 Concarlo www.concarlo.com is a preclinical biotech company whose mission is to transform the treatment of all drug-resistant cancers by leveraging the unique characteristics …See details»
Changing Outcomes for Drug-Resistant Patients
In your lifetime, chances are someone you know will be affected by cancer. In this episode, Stacy Blain, founder, and CSO of Concarlo Therapeutics talks about how she and a team of …See details»
Jay Campbell - Business Advisor at Concarlo Holdings | The Org
Jay is currently Managing Director of the Clinical Accelerator and Venture fund at the Cancer Research Institute where he oversees the organization’s clinical trials and venture investing. …See details»
Concarlo Holdings LLC: 药物管线，专利，临床试验 - 智慧芽新药情 …
Concarlo Therapeutics Vadim Shepel, Chief Business & Operating Officer Concarlo Therapeutics Senior Leader Brings Deep Biotech and Pharmaceutical Industry Experience BROOKLYN, …See details»
News - Concarlo Therapeutics
Our News Presentations and Publications Concarlo in the News Webinars & Talks Awards Presentations & Publications Concarlo in the News Webinars & Talks Awards “The reward for …See details»
Concarlo Holdings Reviews: What Is It Like to Work At Concarlo …
1 Concarlo Holdings reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»